| Model Number |
AH+3013-1M |
| Medical Device Problem Code |
Patient-Device Incompatibility (2682)
|
| Health Effect - Clinical Code |
Rash (2033)
|
| Date of Event |
09/03/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Four patients developed rashes following glp-1 medication injections administered for the treatment of obesity.None of the patients had a history of known allergies, and no injuries, medical interventions, or hospitalizations were required as a result of the reactions.The facility subsequently switched to a different lot of the product.All affected patients recovered fully, and the used product was discarded by the facility.
|
| |
|
Additional Manufacturer Narrative
|
|
Final investigation report attached is on retained unused samples only.
|
| |
|
Event or Problem Description
|
|
Four patients developed rashes following glp-1 medication injections administered for the treatment of obesity.None of the patients had a history of known allergies, and no injuries, medical interventions, or hospitalizations were required as a result of the reactions.The facility subsequently switched to a different lot of the product.All affected patients recovered fully, and the used product was discarded by the facility.
|
| |
|
Search Alerts/Recalls
|